m-AMSA: a new anticancer agent.
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA; NSC-249992) is a new anticancer agent that has undergone extensive experimental investigation. Clinical trials have recently been initiated and current data suggest a wide spectrum of antitumor activity in human cancer.
D000609:Aminoacridines / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D000677:Amsacrine; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000677:Amsacrine